Literature DB >> 225253

The effects of growth hormone, thyroxine and insulin on the activities of reduced nicotinamide adenine dinucleotide phosphate dehydrogenase, glucose-6-phosphatase and glycogen phosphorylase in fetal rat liver.

S P Porterfield.   

Abstract

Growth hormone (GH), thyroxine (T4) and insulin were injected, in utero into 20.5 day-old rat fetuses to study the effects of these hormones on the activities of liver NADPH dehydrogenase, glucose-6-phosphatase and glycogen phosphorylase. It was found that at 21.5 days of gestation, GH increases the fetal liver glucose-6-phosphatase activity and decreases the liver glycogen phosphorylase activity. T4 treatment augments the activity of NADPH dehydrogenase even at 0.3% of the dose shown previously to produce premature elevation of activity. Prior to this experiment T4 in large doses has been shown to be capable of elevating glucose-6-phosphatase. However, at the lower T4 dose used, no treatment effect was observed. The fetal rat liver is responsive to insulin at 21.5 days and insulin was able to depress glucose-6-phosphatase activity. Thereby, showing that the influence of insulin on this enzyme begins prior to birth instead of just subsequent to birth.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225253     DOI: 10.1055/s-0028-1092757

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  2 in total

Review 1.  Regulation of liver development: implications for liver biology across the lifespan.

Authors:  Philip A Gruppuso; Jennifer A Sanders
Journal:  J Mol Endocrinol       Date:  2016-02-17       Impact factor: 5.098

2.  Role of leptin in the regulation of growth and carbohydrate metabolism in the ovine fetus during late gestation.

Authors:  Alison J Forhead; Christopher A Lamb; Kathryn L Franko; Deirdre M O'Connor; F B Peter Wooding; Roselle L Cripps; Susan Ozanne; Dominique Blache; Qingwu W Shen; Min Du; Abigail L Fowden
Journal:  J Physiol       Date:  2008-03-06       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.